Expert Opinion on Therapeutic Targets 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dapagliflozin modulates neuronal injury via instigation of LKB1/p-AMPK/GABAB R2 signaling pathway and suppression of the inflammatory cascade in an essential tremor rat model
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - May 2, 2023 Category: Drugs & Pharmacology Authors: Ahmed S. Kamel Sama M. Farrag Heba M. Mansour Noha N. Nassar Muhammed A. Saad Source Type: research
Emerging therapeutic targets for anorexia nervosa
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 28, 2023 Category: Drugs & Pharmacology Authors: Andreas Stengel Katrin Giel Source Type: research
Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 11, 2023 Category: Drugs & Pharmacology Authors: Sonal M. Manohar Kalpana S. Joshi Source Type: research
Advances in molecular therapies for targeting pathophysiology in spinal cord injury
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - April 5, 2023 Category: Drugs & Pharmacology Authors: Ha Neui Kim Madeline R. McCrea Shuxin Li Source Type: research
Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 31, 2023 Category: Drugs & Pharmacology Authors: Bo Xie Yuqi Zhu Yuqing Shen Wen Xu Xiuzu Song Source Type: research
Papain exerts an anti-atherosclerosis effect with suppressed MPA-mediated foam cell formation by regulating the MAPK and PI3K/Akt-NF- κB pathways
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 24, 2023 Category: Drugs & Pharmacology Authors: Xianming Fei Lianlian Pan Wufen Yuan Yan Zhao Lei Jiang Qinghua Huang Yan Wu Guoqing Ru Source Type: research
Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy
Volume 27, Issue 2, February 2023, Page 91-95 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 23, 2023 Category: Drugs & Pharmacology Authors: Maurilio Sampaolesi Stefan Janssens Robin Duelen Source Type: research
Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 23, 2023 Category: Drugs & Pharmacology Authors: Maurilio Sampaolesi Stefan Janssens Robin Duelen Source Type: research
Myocarditis: causes, mechanisms, and evolving therapies
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 22, 2023 Category: Drugs & Pharmacology Authors: Tin Kyaw Grant Drummond Alex Bobik Karlheinz Peter Source Type: research
Parasite and host kinases as targets for antimalarials
Volume 27, Issue 2, February 2023, Page 151-169 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - March 21, 2023 Category: Drugs & Pharmacology Authors: Han Wee Ong Jack Adderley Andrew B. Tobin David H. Drewry Christian Doerig Source Type: research
